UB Paderborn / Katalog / Suche / in CDI

Angiosarcoma

The lancet oncology, 2010-10, Vol.11 (10), p.983-991

2010

Volltextzugriff (PDF)

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial

The lancet oncology, 2017-08, Vol.18 (8), p.1116-1125

2017

Volltextzugriff (PDF)

Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma

Journal of clinical oncology, 2011-03, Vol.29 (9), p.1125-1132

2011

Volltextzugriff (PDF)

Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial

The lancet oncology, 2012-10, Vol.13 (10), p.1045-1054

2012

Volltextzugriff (PDF)

Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium

International journal of cancer, 2015-02, Vol.136 (4), p.894-903

2015

Volltextzugriff (PDF)

Optimizing the yield and utility of circulating cell-free DNA from plasma and serum

Clinica chimica acta, 2009-06, Vol.404 (2), p.100-104

2009

Volltextzugriff (PDF)

Overcoming CYP1A1/1A2 Mediated Induction of Metabolism by Escalating Erlotinib Dose in Current Smokers

Journal of clinical oncology, 2009-03, Vol.27 (8), p.1220-1226

2009

Volltextzugriff (PDF)

Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial

The lancet oncology, 2017-10, Vol.18 (10), p.1397-1410

2017

Volltextzugriff (PDF)

Randomized Double-Blind Placebo-Controlled Trial of Thalidomide in Combination With Gemcitabine and Carboplatin in Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2009-11, Vol.27 (31), p.5248-5254

2009

Volltextzugriff (PDF)

The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial

European journal of cancer (1990), 2019-03, Vol.109, p.51-60

2019

Volltextzugriff (PDF)

Randomized Phase III Trial of Standard Therapy Plus Low Molecular Weight Heparin in Patients With Lung Cancer: FRAGMATIC Trial

Journal of clinical oncology, 2016-02, Vol.34 (5), p.488-494

2016

Volltextzugriff (PDF)

Bone-targeted agents in the treatment of lung cancer

Therapeutic Advances in Medical Oncology, 2015-07, Vol.7 (4), p.219-228

2015

Volltextzugriff (PDF)

Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells

BMC cancer, 2008-07, Vol.8 (1), p.218-218, Article 218

2008

Volltextzugriff (PDF)

Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid: Subgroup Analysis from a Randomized Phase 3 Study

Journal of thoracic oncology, 2012-12, Vol.7 (12), p.1823-1829

2012

Volltextzugriff (PDF)

Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors

Supportive care in cancer, 2014-03, Vol.22 (3), p.679-687

2014

Volltextzugriff (PDF)

Oncolytic herpesvirus therapy for mesothelioma – A phase I/IIa trial of intrapleural administration of HSV1716

Lung cancer (Amsterdam, Netherlands), 2020-12, Vol.150, p.145-151

2020

Volltextzugriff (PDF)

Ganetespib in Combination with Pemetrexed-Platinum Chemotherapy in Patients with Pleural Mesothelioma (MESO-02): A Phase Ib Trial

Clinical cancer research, 2020-09, Vol.26 (18), p.4748-4755

2020

Volltextzugriff (PDF)

Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata

British journal of cancer, 2023-10, Vol.129 (9), p.1490-1499

2023

Volltextzugriff (PDF)

Eribulin in soft-tissue sarcoma

The Lancet (British edition), 2016-04, Vol.387 (10028), p.1594-1596

2016

Volltextzugriff (PDF)

Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer risk

Human molecular genetics, 2023-09, Vol.32 (18), p.2842-2855

2023

Volltextzugriff (PDF)

The clinical role of VeriStrat testing in patients with advanced non–small cell lung cancer considered unfit for first-line platinum-based chemotherapy

European journal of cancer (1990), 2019-10, Vol.120, p.86-96

2019

Volltextzugriff (PDF)

The relationship between smoking and quality of life in advanced lung cancer patients: a prospective longitudinal study

Supportive care in cancer, 2016-04, Vol.24 (4), p.1507-1516

2016

Volltextzugriff (PDF)

Anti-angiogenic Therapy Using Thalidomide Combined With Chemotherapy in Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial

JNCI : Journal of the National Cancer Institute, 2009-08, Vol.101 (15), p.1049-1057

2009

Volltextzugriff (PDF)

Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors

Investigational new drugs, 2016-06, Vol.34 (3), p.290-299

2016

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Angiosarcoma

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial

Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma

Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial

Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium

First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial

Optimizing the yield and utility of circulating cell-free DNA from plasma and serum

Overcoming CYP1A1/1A2 Mediated Induction of Metabolism by Escalating Erlotinib Dose in Current Smokers

Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial

Randomized Double-Blind Placebo-Controlled Trial of Thalidomide in Combination With Gemcitabine and Carboplatin in Advanced Non–Small-Cell Lung Cancer

The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial

Randomized Phase III Trial of Standard Therapy Plus Low Molecular Weight Heparin in Patients With Lung Cancer: FRAGMATIC Trial

Bone-targeted agents in the treatment of lung cancer

Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells

Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid: Subgroup Analysis from a Randomized Phase 3 Study

Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors

Oncolytic herpesvirus therapy for mesothelioma – A phase I/IIa trial of intrapleural administration of HSV1716

Ganetespib in Combination with Pemetrexed-Platinum Chemotherapy in Patients with Pleural Mesothelioma (MESO-02): A Phase Ib Trial

Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata

Eribulin in soft-tissue sarcoma

Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer risk

The clinical role of VeriStrat testing in patients with advanced non–small cell lung cancer considered unfit for first-line platinum-based chemotherapy

The relationship between smoking and quality of life in advanced lung cancer patients: a prospective longitudinal study

Anti-angiogenic Therapy Using Thalidomide Combined With Chemotherapy in Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial

Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors

Suchergebnisse filtern